Transoral incisionless fundoplication with or without hiatal hernia repair for gastroesophageal reflux disease after peroral endoscopic myotomy

Abstract

Background and study aims Gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM) occurs in 40% to 60% of patients. There are limited data evaluating antireflux surgery or transoral incisionless fundoplication (TIF) for refractory post-POEM GERD.

Patients and methods In a single-center prospective cohort study, consecutive patients with medically refractory post-POEM regurgitation and/or GERD treated with TIF or combined laparoscopic hernia repair and TIF (cTIF) were evaluated. Baseline evaluation: GERD-Health Related Quality of Life (GERD-HQRL) and Reflux Symptom Questionnaire 7-day recall (RESQ-7) questionnaires, EGD, high-resolution manometry (HRM), 48-hour pH test off proton pump inhibitors (PPIs) and impedance planimetry of the esophagogastric junction (EGJ) to calculate the diameter distensibility index (EGJ-DI). A PPI was taken twice daily for 2 weeks after TIF and restarted later if required. Patients returned 9 to 12 months after treatment when all preoperative studies were repeated. Quality of life, pH studies and EGJ metrics before and after antireflux surgery were compared.

Results Seventeen patients underwent TIF (n=2, 12%) or cTIF (n=15, 88%) a mean 25±15 months after POEM. At follow-up a mean of 9±1 months after TIF/cTIF, patients required less frequent daily PPIs (n=0.001), were more satisfied (P=0.008), had improved GERD-HQRL (P=0.001), less intensity and frequency of GERD (P=0.001) and fewer reflux episodes (P=0.04) by pH testing. There was no change in EGJ-DI, EGJ diameter, integrated relaxation pressure, % total time pH <4, or DeMeester score.

Conclusions TIF and cTIF for difficult-to-control post-POEM GERD appear safe, decrease PPI use and reflux episodes, and improve QOL without significant change in IRP, EGJ compliance, diameter or esophageal acid exposure time.

Keywords

Reflux disease - Motility / achalasia - POEM

Publication History

Received: 15 September 2023

Accepted after revision: 16 November 2023

Accepted Manuscript online:
21 November 2023

Article published online:
05 January 2024

• References

• 1 Werner YB, Hakanson B, Martinek J. et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med 2019; 381: 2219-2229 DOI: 10.1056/NEJMoa1905380. (PMID: 31800987)
• 2 Repici A, Fuccio L, Maselli R. et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018; 87: 934-943
• 3 Bello B, Zoccali M, Gullo R. et al. Gastroesophageal reflux disease and antireflux surgery - what is the proper preoperative work-up?. J Gastrointest Surg 2013; 17: 14-20 discussion p.20
• 4 Schlottmann F, Luckett DJ, Fine J. et al. Laparoscopic heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg 2018; 267: 451-460 DOI: 10.1097/SLA.0000000000002311. (PMID: 28549006)
• 5 Talukdar R, Inoue H, Reddy DN. Efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surg Endosc 2015; 29: 3030-3046
• 6 Akintoye E, Kumar N, Obaitan I. et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy 2016; 48: 1059-1068 DOI: 10.1055/s-0042-114426. (PMID: 27617421)
• 7 Dewitt JM, Kessler WR, Wo JM. et al. symptom association for gastroesophageal reflux disease by pH monitoring after peroral endoscopic myotomy. Am J Gastroenterol 2022; 117: 1316-1319 DOI: 10.14309/ajg.0000000000001801. (PMID: 35467562)
• 8 Nabi Z, Ramchandani M, Kotla R. et al. Gastroesophageal reflux disease after peroral endoscopic myotomy is unpredictable, but responsive to proton pump inhibitor therapy: a large, single-center study. Endoscopy 2020; 52: 643-651 DOI: 10.1055/a-1133-4354. (PMID: 32208499)
• 9 Nurczyk K, Farrell TM, Patti MG. Antireflux surgery for gastroesophageal reflux refractory to medical treatment after peroral endoscopic myotomy. J Laparoendosc Adv Surg Tech A 2020; 30: 612-614 DOI: 10.1089/lap.2020.0106. (PMID: 32240031)
• 10 Maydeo A, Patil G, Kamat N. et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux after peroral endoscopic myotomy: a randomized sham-controlled study. Endoscopy 2023; 55: 689-698 DOI: 10.1055/a-2040-4042. (PMID: 36944359)
• 11 Tyberg A, Choi A, Gaidhane M. et al. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal. Endosc Int Open 2018; 6: E549-E552 DOI: 10.1055/a-0584-6802. (PMID: 29756011)
• 12 Brewer Gutierrez OI, Chang KJ. et al. Is transoral incisionless fundoplication (TIF) an answer to post-peroral endoscopic myotomy gastroesophageal reflux? A multicenter retrospective study. Endoscopy 2022; 54: 305-309
• 13 Benias PC, Kumbhari V, Kumta NA. et al. Single session per oral endoscopic myotomy and trans oral incisionless fundoplication – can we prevent reflux in patients with achalasia?. Endosc Int Open 2021; 9: E828-E835
• 14 Pandolfino JE, de Ruigh A, Nicodème F. et al. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil 2013; 25: 496-501
• 15 DeWitt JM, Siwiec R, Kessler WR. et al. Comparison of functional lumen imaging probe and high-resolution manometry to assess response after peroral endoscopic myotomy. Gastrointest Endosc 2022; 95: 855-863 DOI: 10.1016/j.gie.2021.12.029. (PMID: 34979118)
• 16 Lundell LR, Dent J, Bennett JR. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
• 17 Hill LD, Kozarek RA. The gastroesophageal flap valve. J Clin Gastroenterol 1999; 28: 194-197 DOI: 10.1097/00004836-199904000-00002. (PMID: 10192602)
• 18 Gyawali CP, Kahrilas PJ, Savarino E. et al. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018; 67: 1351-1362
• 19 Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 2007; 20: 130-134 DOI: 10.1111/j.1442-2050.2007.00658.x. (PMID: 17439596)
• 20 Rydén A, Leavy OC, Halling K. et al. Comparison of daily versus weekly recording of gastroesophageal reflux disease symptoms in patients with a partial response to proton pump inhibitor therapy. Value Health 2016; 19: 829-833
• 21 Bell RC, Cadière GB. Transoral esophago-gastric fundoplication: technical and safety considerations. Surg Endosc 2011; 25: 2387-2399
• 22 Janu P, Shughoury AB, Venkat K. et al. Laparoscopic Hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX Device (HH + TIF): Efficacy and safety in two community hospitals. Surg Innov 2019; 26: 675-686
• 23 Nguyen NT, Chinn J, Chang K. Collaboration between GI surgery & Gastroenterology improves understanding of the optimal antireflux valve-the omega flap valve. Surg Endosc 2021; 35: 3214-3220 DOI: 10.1007/s00464-021-08416-y. (PMID: 33709228)
• 24 Shiwaku H, Inoue H, Shiwaku A. et al. Safety and effectiveness of sling fiber preservation POEM to reduce severe post-procedural erosive esophagitis. Surg Endosc 2022; 36: 4255-4264 DOI: 10.1007/s00464-021-08763-w. (PMID: 34716481)
• 25 Khashab MA, Sanaei O, Rivory J. et al. Peroral endoscopic myotomy: anterior versus posterior approach: a randomized single-blinded clinical trial. Gastrointest Endosc 2020; 91: 288-297 DOI: 10.1016/j.gie.2019.07.034. (PMID: 31408652)
• 26 Li QL, Chen WF, Zhou PH. et al. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg 2013; 217: 442-451
• 27 Familiari P, Borrelli de Andreis F. et al. Long versus short peroral endoscopic myotomy for the treatment of achalasia: results of a non-inferiority randomised controlled trial. Gut 2023; 72: 1442-1450
• 28 Werner YB, Hakanson B, Martinek J. et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med 2019; 381: 2219-2229 DOI: 10.1056/NEJMoa1905380. (PMID: 31800987)
• 29 Inoue H, Ueno A, Shimamura Y. et al. Peroral endoscopic myotomy and fundoplication: a novel NOTES procedure. Endoscopy 2019; 51: 161-164 DOI: 10.1055/a-0820-2731. (PMID: 30654395)
• 30 Bapaye A, Dashatwar P, Dharamsi S. et al. Single-session endoscopic fundoplication after peroral endoscopic myotomy (POEM+F) for prevention of post gastroesophageal reflux – 1-year follow-up study. Endoscopy 2021; 53: 1114-1121 DOI: 10.1055/a-1332-5911. (PMID: 33291157)
• 31 Gerson L, Stouch B, Lobontiu A. Transoral incisionless fundoplication (TIF 2.0): A meta-analysis of three randomized, controlled clinical trials. Chirurgia (Bucur) 2018; 113: 173-184 DOI: 10.21614/chirurgia.113.2.173. (PMID: 29733015)
• 32 Trad KS, Barnes WE, Simoni G. et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: The TEMPO Randomized Clinical Trial. Surg Innov 2015; 22: 26-40 DOI: 10.1177/1553350614526788. (PMID: 24756976)
• 33 Hunter JG, Kahrilas PJ, Bell RC. et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology 2015; 148: 324-333 DOI: 10.1053/j.gastro.2014.10.009. (PMID: 25448925)
• 34 Hakansson B, Montgomery M, Cadiere GB. et al. Randomised clinical trial: Transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015; 42: 1261-1270 DOI: 10.1111/apt.13427. (PMID: 26463242)
• 35 Testoni S, Hassan C, Mazzoleni G. et al. Long-term outcomes of transoral incisionless fundoplication for gastroesophageal reflux disease: systematic-review and meta-analysis. Endosc Int Open 2021; 9: E239-E246 DOI: 10.1055/a-1322-2209. (PMID: 33553587)